A Multicenter, Randomized Trial of the Inhibitory Effect of NSAIDs for APR in Primary Osteoporosis Patients Administered Zoledronic Acid
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Zoledronic acid (Primary) ; Loxoprofen
- Indications Osteoporosis
- Focus Adverse reactions
- 11 Sep 2017 Planned End Date changed from 7 Oct 2017 to 7 Nov 2017.
- 14 Mar 2017 New trial record
- 11 Mar 2017 Planned End Date changed from 30 Sep 2017 to 7 Oct 2017.